Coronavirus company news summary – LogicInk and Contakt World partner to accelerate development of Covid-19 Biosensor Sticker – DnaNudge launches lab-standard 90-minute Covid-19 Bubble Test

11 November 2020 (Last Updated November 11th, 2020 09:46)

AnPac Bio-Medical Science has completed US Food and Drug Administration (FDA) approved antibody test verification in its California lab this month. The Roche Elecsys Anti Sars-COV-2 test will now enter the commercial stage testing, with the Covid-19 antibody test equipment also installed in its Philadelphia lab.

LumiraDx, a diagnostic company, has announced a $32m global partnership with Africa Union, Africa Medical Supplies Platform (AMSP), Africa Centres for Disease Control and Prevention, Bill and Melinda Gates Foundation, and Clinton Health Access Initiative along with the Mastercard and the Rockefeller Foundations to expand and accelerate testing in Africa. LumiraDx will provide 5,000 portable diagnostic instruments and related Covid-19 antigen tests, while AMSP will supply it equitably across 55 African Union member states

LogicInk and Contakt World Technologies Corp announced a collaboration and signed a Memorandum of Understanding (MOU) to fast-track the development of LogicInk’s non-invasive, biosensor sticker for Covid-19. LogicInk’s new signal will enable self-administration and interpret results for the SARS-CoV-2 infection by simply identifying a colour combination.

DnaNudge, which created the rapid, lab-free CovidNudge test used by the NHS, announced the launch of the 90-minute Covid-19 Bubble Test, offering group testing on one cartridge for bubbles up to 10 people with no coronavirus symptoms. The breakthrough test is now available for online booking and through appointment only from DnaNudge’s London’s Covent Garden. It will also be made available as an at-home, by-post service within weeks in the UK.